title: National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.
abstract: There have been several articles and reports in recent months about comorbidities and risks that affect psoriasis patients in addition to their underlying disease. This piece reviews the current literature and begins to address what should be done with this new information by updating the clinician about what health screening tests, preventative exams, and referrals should be considered in this population.
authors.affiliation: Department of Dermatology, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114, USA. harvardskinstudies@partners.org
authors.forename: Alexa B
authors.initials: AB
authors.lastname: Kimball
authors.forename: Dafna
authors.initials: D
authors.lastname: Gladman
authors.forename: Joel M
authors.initials: JM
authors.lastname: Gelfand
authors.forename: Kenneth
authors.initials: K
authors.lastname: Gordon
authors.forename: Elizabeth J
authors.initials: EJ
authors.lastname: Horn
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Korman
authors.forename: Gretchen
authors.initials: G
authors.lastname: Korver
authors.forename: Gerald G
authors.initials: GG
authors.lastname: Krueger
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Strober
authors.forename: Mark G
authors.initials: MG
authors.lastname: Lebwohl
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications; D006801:Humans; D007239:Infections / Q000150:complications; D009369:Neoplasms / Q000150:complications; D011565:Psoriasis / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D012307:Risk Factors